v3.26.1
Fair Value Measurements - Schedule of Assets Measured at Fair Value on a Recurring Basis (Details) - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Assets    
Short-term investments $ 0 $ 62,944,000
Recurring    
Assets    
Total cash equivalents 62,034,000 34,378,000
Recurring | Short-term investments    
Assets    
Total short-term investments 21,000 62,976,000
Recurring | Money market mutual funds    
Assets    
Total cash equivalents 62,034,000 29,379,000
Recurring | Scilex Holding Company common stock | Short-term investments    
Assets    
Short-term investments 21,000 30,000
Recurring | Sorrento Therapeutics, Inc. Common Stock | Short-term investments    
Assets    
Short-term investments   2,000
Recurring | U.S. Treasury obligations    
Assets    
Total cash equivalents   4,999,000
Recurring | U.S. Treasury obligations | Short-term investments    
Assets    
Short-term investments   62,944,000
Level 1 | Recurring    
Assets    
Total cash equivalents 62,034,000 29,379,000
Level 1 | Recurring | Short-term investments    
Assets    
Total short-term investments 21,000 32,000
Level 1 | Recurring | Money market mutual funds    
Assets    
Total cash equivalents 62,034,000 29,379,000
Level 1 | Recurring | Scilex Holding Company common stock | Short-term investments    
Assets    
Short-term investments $ 21,000 30,000
Level 1 | Recurring | Sorrento Therapeutics, Inc. Common Stock | Short-term investments    
Assets    
Short-term investments   2,000
Level 2 | Recurring    
Assets    
Total cash equivalents   4,999,000
Level 2 | Recurring | Short-term investments    
Assets    
Total short-term investments   62,944,000
Level 2 | Recurring | U.S. Treasury obligations    
Assets    
Total cash equivalents   4,999,000
Level 2 | Recurring | U.S. Treasury obligations | Short-term investments    
Assets    
Short-term investments   $ 62,944,000